The Claim
IDE deficiency in C57BL/6 and NOD mice is associated with increased beta cell proliferation and islet hypertrophy at steady state, along with elevated insulin and IAPP levels, indicating a regulatory role for IDE in beta cell mass and peptide homeostasis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In C57BL/6 and NOD mice, the absence of IDE leads to higher rates of beta cell division, larger pancreatic islets, and increased levels of insulin and IAPP, suggesting IDE normally constrains beta cell growth and peptide balance.
See the scientific wording
IDE deficiency in C57BL/6 and NOD mice is associated with increased beta cell proliferation and islet hypertrophy at the steady state, accompanied by elevated insulin and IAPP levels, suggesting a role for IDE in regulating beta cell mass and peptide homeostasis.
When the enzyme that breaks down insulin and IAPP is missing, these molecules build up inside insulin-producing cells. This overload stresses the cell's protein-making factory, which sends a signal to turn on a growth program. That program tells the cells to make more proteins and divide more often, causing the islets to get bigger and produce more insulin. The cells also develop abnormal storage containers for insulin, which disrupts normal release.
What the research says
1 studyWhen mice don’t have the IDE enzyme, their insulin-producing cells grow bigger and multiply more, making more insulin and a similar molecule. This shows IDE normally keeps these cells in check.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.